DEVONY HITT: Open Payments
NPI 1679771604 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 31 payments from 11 companies in 2025. Trend: 2023 $904 · 2024 $1,212 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $305 |
| AstraZeneca Pharmaceuticals LP | 4 | $180 |
| Novo Nordisk Inc | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $85 |
| ABBVIE INC. | 3 | $56 |
| PFIZER INC. | 3 | $49 |
| DJO, LLC | 1 | $28 |
| Curonix LLC | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $14 |
Products named: Auvelity, AIRSUPRA, CAPLYTA, VRAYLAR, Ozempic, Rybelsus, NURTEC ODT, CMF.
Industry payments across TN — which companies pay providers there.
